Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in VCEL — Vericel Corp

CIK 80255 BALTIMORE, MD
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,356,414
+$1,337,972 QoQ
Shares Held
75,442
+20.2% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 317 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. VCEL ranks #139 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in VCEL

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,356,414 75,442
2026-03-31 $2,018,442 62,743
2025-12-31 $1,794,522 49,834
2025-09-30 $1,387,480 44,089
2025-06-30 $1,765,527 41,493
2025-03-31 $1,649,333 36,964
2024-12-31 $1,618,691 29,479
2024-09-30 $1,282,160 30,347
2024-06-30 $1,335,199 29,102
2024-03-31 $1,419,105 27,280
2023-12-31 $910,155 25,559
2023-09-30 $851,039 25,389
2023-06-30 $850,735 22,644
2023-03-31 $647,414 22,081
2022-12-31 $559,435 21,239
2022-09-30 $478,917 20,643
2022-06-30 $441,808 17,546
2022-03-31 $758,781 19,853
2021-12-31 $718,207 18,275
2021-09-30 $1,073,307 21,994
2021-06-30 $983,062 18,725
2021-03-31 $998,066 17,967